Status:
NOT_YET_RECRUITING
Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism
Lead Sponsor:
Ruijin Hospital
Conditions:
Primary Aldosteronism
Eligibility:
All Genders
18-75 years
Brief Summary
This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indi...
Detailed Description
Patients suspected of having primary aldosteronism and admitted for treatment, who are diagnosed with primary aldosteronism through at least one confirmatory test, and subsequently diagnosed with unil...
Eligibility Criteria
Inclusion
- Patients diagnosed with unilateral primary aldosteronism who undergo surgical treatment and have their cortical function assessed by an ACTH stimulation test within one week postoperatively.
Exclusion
- Patients using medications that affect adrenal cortical function.
- Patients with a history of adrenal surgery
- Pregnant or breastfeeding women
- Patients with severe underlying diseases (such as liver or kidney failure) that may affect adrenal cortical function
Key Trial Info
Start Date :
August 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06534268
Start Date
August 15 2024
End Date
July 30 2026
Last Update
August 2 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.